InvestorsHub Logo
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: jon_k84 post# 175440

Friday, 06/01/2018 2:46:33 PM

Friday, June 01, 2018 2:46:33 PM

Post# of 700911
Nice write up Jon.

Pretty well agree with you except on LP's motivation.
Big Pharma and most investors expected her to do what most early stage bio's have to do, which is sell up and pocket the money as reward for their early scientific development.
BP rely on scientific innovation by others and then just get the chequebook out.
LP could have sold out two years when her personal stock was valued at something like $50million. Who needs more than that?

We know she has been affected by several members of her close family falling victim to cancer.

What she wants is to leave a legacy. That doesn't mean I don't think she will never relinquish control. But I imagine she wants to see L and Direct firmly established as the SOC for solid cancers around the world, and the company firmly established as the world leader.

Then, she will take a back seat.

She is single-minded and means what she says.
Go big or go home.
There's risk there, because there is no safety net.
Some sort of partnership might be on the cards however.
I think she would rather take venture capital from the people who funded the Cognate deal, than sell out to BP.

Everything you say about the critical importance of staying blind to reap the maximum possible stat power from the long tail, I've been saying for months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News